title: The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting.
abstract: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Most GIST harbor a mutation affecting either the KIT or PDGFRA genes, whereas a small subgroup of tumors is wild type for mutations.Mutation of tyrosine kinase receptors is a mechanism of drug resistance that can occur either at the beginning of treatment (primary resistance) or during the course of therapy (secondary resistance). In addition, mutational status can predict the response to treatment with tyrosine kinase inhibitors, but the role of mutational status as a prognostic factor remains controversial.Evidence of a potential role of mutational status as a prognostic factor has emerged over the past decade. The presence of KIT exon 11 insertion/deletion involving either one or both Trp557-Lys558 amino acids correlates with a poorer clinical outcome if compared to patients with tumors wild type for KIT exon 11 mutations. A malignant clinical behavior has also been documented for KIT exon 13 and KIT exon 9 mutant GIST. Patients with GIST harboring a PDGFRA mutation seem to have a better prognosis than the others.The aim of this paper is to review the clinical significance of tyrosine kinase mutational status.
authors: "L,&A,Seragnoli" Department of Hematology and Oncological Sciences, S, Orsola-Malpighi Hospital, University of Bologna, Italy. alessandramaleddu@gmail.com
authors: Alessandra
authors: A
authors: Maleddu
authors: Maria A
authors: MA
authors: Pantaleo
authors: Margherita
authors: M
authors: Nannini
authors: Guido
authors: G
authors: Biasco
references: Science. 1998 Jan 23;279(5350):577-80
references: 9438854
references: J Clin Oncol. 2002 Sep 15;20(18):3898-905
references: 12228211
references: Int J Cancer. 2003 Oct 10;106(6):887-95
references: 12918066
references: J Clin Oncol. 2003 Dec 1;21(23):4342-9
references: 14645423
references: Cancer Res. 2001 Nov 15;61(22):8118-21
references: 11719439
references: Am J Pathol. 2000 Mar;156(3):791-5
references: 10702394
references: Science. 2003 Jan 31;299(5607):708-10
references: 12522257
references: Br J Cancer. 2004 Jun 1;90(11):2059-61
references: 15150562
references: Clin Cancer Res. 2003 Aug 15;9(9):3329-37
references: 12960119
references: Clin Cancer Res. 2009 Dec 15;15(24):7510-7518
references: 20008851
references: Lancet. 2001 Oct 27;358(9291):1421-3
references: 11705489
references: Cancer Res. 1999 Sep 1;59(17):4297-300
references: 10485475
references: Lab Invest. 1998 Dec;78(12):1633-6
references: 9881963
references: J Clin Oncol. 2008 Nov 20;26(33):5352-9
references: 18955458
references: Cancer. 2008 Feb 1;112(3):608-15
references: 18076015
references: Oncol Rep. 2006 Jul;16(1):97-101
references: 16786129
references: Eur J Cancer. 2003 Sep;39(14):2006-11
references: 12957454
references: Eur J Cancer. 2006 May;42(8):1093-103
references: 16624552
references: Cancer Res. 2004 Sep 1;64(17):5913-9
references: 15342366
references: J Pathol. 2008 Sep;216(1):64-74
references: 18623623
references: Lab Invest. 2004 Jul;84(7):874-83
references: 15146165
references: Am J Pathol. 2000 Oct;157(4):1091-5
references: 11021812
references: J Clin Oncol. 2005 Aug 10;23(23):5357-64
references: 15928335
references: J Clin Oncol. 2006 Oct 10;24(29):4764-74
references: 16954519
references: Ann Oncol. 2010 Jul;21(7):1552-1557
references: 20231303
references: Oncogene. 2006 Oct 5;25(45):6140-6
references: 16751810
references: Gastroenterology. 2005 Feb;128(2):270-9
references: 15685537
references: Jpn J Cancer Res. 2001 May;92(5):494-8
references: 11376557
references: Histopathology. 2008 Sep;53(3):245-66
references: 18312355
references: Lancet Oncol. 2009 Nov;10(11):1045-52
references: 19793678
references: Clin Cancer Res. 2004 May 1;10(9):3076-81
references: 15131046
references: Lab Invest. 2006 Jan;86(1):94-100
references: 16258521
references: Hum Pathol. 2002 May;33(5):459-65
references: 12094370
references: Eur J Cancer. 2004 Mar;40(5):689-95
references: 15010069
references: Ann Surg. 2000 Jan;231(1):51-8
references: 10636102
references: Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
references: 17090188
references: J Clin Oncol. 2008 Nov 20;26(33):5360-7
references: 18955451
references: Gastric Cancer. 2007;10(3):145-52
references: 17922091
references: Lancet. 2009 Mar 28;373(9669):1097-104
references: 19303137
references: Clin Cancer Res. 2005 Jun 1;11(11):4182-90
references: 15930355
references: Am J Pathol. 1999 Jan;154(1):53-60
references: 9916918
references: J Clin Oncol. 2004 Sep 15;22(18):3813-25
references: 15365079
references: Gastroenterology. 2004 Jul;127(1):294-9
references: 15236194
references: J Clin Oncol. 2008 Feb 1;26(4):626-32
references: 18235122
references: J Clin Oncol. 2005 Sep 1;23(25):6190-8
references: 16135486
references: Cancer Res. 2005 Feb 1;65(3):1115; author reply 1115
references: 15705916
references: Gastroenterology. 2006 May;130(6):1573-81
references: 16697720
references: Am J Surg Pathol. 2004 Jul;28(7):889-94
references: 15223958
references: J Biol Chem. 2003 Feb 14;278(7):5148-55
references: 12435730
references: N Engl J Med. 2002 Aug 15;347(7):472-80
references: 12181401